All 3 editing mediating enzymes, ADAR1 (ADAR), ADAR2 (ADARB1), and ADAR3 (ADARB2), is downregulated in brain tumors and ADARB2 is also negatively correlated with GBM grades. This evidence concerns the gene ADARB2 and brain neoplasm.